{"title": "Industria farmac\u00e9utica en India: invertir en el sector fa...", "author": "Search", "url": "https://www.investindia.gov.in/es-es/sector/pharmaceuticals", "hostname": "investindia.gov.in", "description": "Industria farmac\u00e9utica en India: conozca la inversi\u00f3n, la tasa de crecimiento del mercado, las tendencias futuras, las empresas y la IED en el sector farmac\u00e9utico indio", "sitename": "investindia.gov.in", "date": "2023-09-14", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Instant\u00e1nea\nProductos farmac\u00e9uticos indios: una f\u00f3rmula para el \u00e9xito\nLa industria farmac\u00e9utica india juega un papel destacado en la industria farmac\u00e9utica mundial. India ocupa el tercer lugar a nivel mundial en producci\u00f3n por volumen y el 14 por valor. La naci\u00f3n es el mayor proveedor de medicamentos gen\u00e9ricos a nivel mundial, ocupa una participaci\u00f3n del 20 % en el suministro mundial por volumen y es el principal fabricante de vacunas a nivel mundial. India tambi\u00e9n tiene la mayor cantidad de plantas farmac\u00e9uticas que cumplen con la FDA de EE. UU. fuera de EE. UU. y alberga m\u00e1s de 3000 compa\u00f1\u00edas farmac\u00e9uticas con una s\u00f3lida red de m\u00e1s de 10 500 instalaciones de fabricaci\u00f3n, as\u00ed como un grupo de recursos altamente calificado.\nLa industria farmac\u00e9utica de la India ofrece 60 000 marcas gen\u00e9ricas en 60 categor\u00edas terap\u00e9uticas. Los principales segmentos incluyen medicamentos gen\u00e9ricos, medicamentos OTC, API/medicamentos a granel, vacunas, investigaci\u00f3n y fabricaci\u00f3n por contrato, biosimilares y productos biol\u00f3gicos.\n- Se aprueban incentivos por valor de INR 21,940 crore ($ 3 mil millones)\n- Se espera que el tama\u00f1o del mercado alcance los $ 65 mil millones para 2024 y ~ $ 130 mil millones para 2030\n- Tasa de crecimiento esperada de 11-12% (2020-2030)\n- Costo de fabricaci\u00f3n ~ 33% m\u00e1s bajo que los mercados occidentales\nLas compa\u00f1\u00edas farmac\u00e9uticas indias, habilitadas por su competitividad de precios y buena calidad, han logrado una marca global, con el 60 % de las vacunas del mundo y el 20 % de los medicamentos gen\u00e9ricos provenientes de la India.\nEl 100% de la Inversi\u00f3n Extranjera Directa (IED) en el sector Farmac\u00e9utico est\u00e1 permitida bajo la ruta autom\u00e1tica para productos farmac\u00e9uticos totalmente nuevos.\nSe permite el 100% de IED en el sector farmac\u00e9utico en productos farmac\u00e9uticos brownfield; donde el 74% est\u00e1 permitido bajo la ruta autom\u00e1tica y posteriormente a trav\u00e9s de la ruta de aprobaci\u00f3n del gobierno.\nPara obtener m\u00e1s detalles, consulte\n[la Pol\u00edtica de FDI](https://www.investindia.gov.in/foreign-direct-investment)\n- %\nCuota de exportaciones de medicamentos gen\u00e9ricos (mundial)\n- ps mil millones\nValor de las exportaciones (AF 21-22)\n- ps mil millones\nIED (abril 2021-marzo 2022)\n- ps mil millones\nIED (abril 2000- marzo 2022)\nEl mayor productor de vacunas del mundo.\nMayor fabricante y exportador de medicamentos gen\u00e9ricos\nLa industria farmac\u00e9utica india genera m\u00e1s de $ 11 mil millones de super\u00e1vit comercial cada a\u00f1o\n- Escenario de la industria\n- FOREIGN INVESTMENT\n- INDUSTRY TRENDS\n- POL\u00cdTICAS Y ESQUEMAS\nEscenario de la industria\nSe espera que la industria farmac\u00e9utica en la India alcance los 65.000 millones de d\u00f3lares para 2024 y los 120.000 millones de d\u00f3lares para 2030\nLa industria farmac\u00e9utica en la India est\u00e1 valorada actualmente en 50.000 millones de d\u00f3lares.\nIndia es un importante exportador de productos farmac\u00e9uticos, con m\u00e1s de 200 pa\u00edses atendidos por las exportaciones farmac\u00e9uticas indias. India suministra m\u00e1s del 50 % de los requisitos de gen\u00e9ricos de \u00c1frica, ~40 % de la demanda de gen\u00e9ricos en los EE. UU. y ~25 % de todos los medicamentos en el Reino Unido.\nIndia tambi\u00e9n representa ~60% de la demanda mundial de vacunas y es un proveedor l\u00edder de vacunas DPT, BCG y contra el sarampi\u00f3n. El 70% de las vacunas de la OMS (seg\u00fan el calendario de inmunizaci\u00f3n esencial) provienen de la India.\nExportaciones de Drogas y Productos Farmac\u00e9uticos se valoran en $ 2052,78 mn en septiembre de 2022 y participa el 6,29% del total exportado del mes. El \u00edndice promedio de producci\u00f3n industrial de fabricaci\u00f3n de productos farmac\u00e9uticos, qu\u00edmicos medicinales y bot\u00e1nicos en el a\u00f1o fiscal 2021-22 es de 221,6 y ha crecido un 1,3%\nPara el per\u00edodo 2021-22, la exportaci\u00f3n de medicamentos y productos farmac\u00e9uticos se situ\u00f3 en $ 24,6 mil millones en comparaci\u00f3n con $ 24,44 mil millones en 2020-21. La industria farmac\u00e9utica india experiment\u00f3 un crecimiento exponencial del 103 % durante 2014-22, de 11 600 millones de d\u00f3lares a 24 600 millones de d\u00f3lares.\nCONTROLADORES DE CRECIMIENTO\nApoyo del gobierno\nIncentivos gubernamentales que incluyen un desembolso de INR 21940 para PLI 1.0 y PLI 2.0\nTurismo m\u00e9dico\nServicios de calidad a costos marginales en comparaci\u00f3n con EE. UU., Europa y el sur de Asia\nDesarrollo de infraestructura\nIndia tiene el mayor n\u00famero de plantas que cumplen con la FDA de los EE. UU. fuera de los EE. UU.\nFuerte fabricaci\u00f3n de medicamentos\nExperiencia en medicamentos gen\u00e9ricos patentados de bajo costo, as\u00ed como en fabricaci\u00f3n de extremo a extremo\nFuerte demanda interna\nLanzamiento del Esquema Nacional de Protecci\u00f3n de la Salud m\u00e1s grande del mundo\nPortal del Banco de Suelo Industrial\nMapa basado en GIS que muestra la infraestructura disponible para establecer operaciones comerciales en el estado.\nGrandes inversores\nDatos en el mapa\nGaler\u00eda\n\u00daltimas noticias\nLo \u00faltimo en productos farmaceuticos\n[Pol\u00edtica de IED 2020](JavaScript:Void(0);)Oct 31, 2020\nDPIIT public\u00f3 la 'Pol\u00edtica consolidada de IED' (vigente a partir del 15 de octubre de 2020)\n[Lee ahora](https://static.investindia.gov.in/s3fs-public/2020-10/FDI-PolicyCircular-2020.pdf)\nPol\u00edtica de IED 2020\nDPIIT public\u00f3 la 'Pol\u00edtica consolidada de\u2026\nPortal\nBanco de tierras industriales de la India\nReporte\n\u00cdndice de habilidades: medici\u00f3n entre\u2026\nInforme\nDoing Business India 2020\nReporte\nAyudando a India a respirar: fabricaci\u00f3n de\u2026\nPreguntas frecuentes\nFrequently\nAsked Questions\n[VER TODO](/frequently-asked-questions?category=7#tabs-82)\nInvest India trabaja estrechamente con\nMinisterio/Departamento de Gobierno\nNew India Timeline @2047\n[Cabinet approves signing of MoU between India and Suriname in the field of the regulation of medicines](/team-india-news/cabinet-approves-signing-mou-between-india-and-suriname-field-regulation-medicines)\nA Memorandum of Understanding (MoU) was signed between the Indian Pharmacopoeia\n[... Visit Page](/team-india-news/cabinet-approves-signing-mou-between-india-and-suriname-field-regulation-medicines)\nDisclaimer: All views and opinions that may be expressed in the posts on this page as well as post emanating from this page are solely of the individual in his/her personal capacity", "language": null, "image": null, "pagetype": "faqpage", "links": ["/search-results?term=fdi policy", "/search-results?term=taxation in india", "/search-results?term=major investors", "/", "/es-es/", "/es-esjavascript:void(0)", "/es-es/about-us", "/es-es/careers", "/es-es/success-stories", "/es-es/invest-india-partners", "/es-es/events", "/es-es/invest-india-team", "/es-es/request-for-proposal", "/es-es/from-our-partners", "/es-esjavascript:void(0)", "/es-es/agnii", "/es-es/atmanirbhar-niveshak-mitra", "/es-es/bonded-manufacturing", "/es-es/central-services-window", "/es-es/financial-investors-initiative", "https://iis.ncog.gov.in/parks/login1", "/es-es/india-investment-grid", "https://www.nsws.gov.in/", "/es-es/one-district-one-product", "/es-es/pm-stiac", "/es-es/pio-investor-helpdesk", "https://pmg.dpiit.gov.in/", "/es-es/corporate-social-responsibility", "/es-es/startup-india-hub", "/es-es/indian-unicorn-landscape", "/es-es/state-single-window", "/es-es/waste-to-wealth", "/es-esjavascript:void(0)", "/es-es/sectors", "/es-es/sector/agriculture-allied-sector", "/es-es/sector/animal-husbandry-and-dairying", "/es-es/sector/animal-husbandry-and-dairying/dairy", "/es-es/sector/auto-components", "/es-es/sector/automobile", "/es-es/sector/automobile/electric-mobility", "/es-es/sector/aviation", "/es-es/sector/ayush", "/es-es/sector/bfsi-fintech-financial-services", "/es-es/sector/bfsi-banking", "/es-es/sector/bfsi-insurance", "/es-es/sector/biotechnology", "/es-es/sector/capital-goods", "/es-es/sector/chemicals", "/es-es/sector/construction", "/es-es/sector/construction/construction-materials", "/es-es/sector/construction/real-estate-commercial", "/es-es/sector/consumer-goods/furniture", "/es-es/sector/consumer-goods/furniture", "/es-es/sector/consumer-goods/personal-care-hygiene", "/es-es/sector/consumer-goods/toys-manufacturing", "/es-es/sector/consumer-goods/white-goods", "/es-es/sector/defence-manufacturing", "/es-es/sector/electronic-systems", "/es-es/sector/electronic-systems/electronic-components-manufacturing", "/es-es/sector/electronic-systems/semi-conductors", "/es-es/sector/fisheries-aquaculture", "/es-es/sector/food-processing", "/es-es/sector/food-processing/fruits-vegetables", "/es-es/sector/healthcare", "/es-es/sector/healthcare/medical-value-travel", "/es-es/sector/it-bpm", "/es-es/sector/leather", "/es-es/sector/media", "/es-es/sector/media/gaming", "/es-es/sector/medical-devices", "/es-es/sector/metals-mining", "/es-es/sector/oil-gas", "/es-es/sector/paper-packaging", "/es-es/sector/pharmaceuticals", "/es-es/sector/ports-shipping", "/es-es/sector/railways", "/es-es/sector/renewable-energy", "/es-es/sector/retail-e-commerce", "/es-es/sector/retail-e-commerce/e-commerce", "/es-es/sector/retail-e-commerce/food-retail", "/es-es/sector/roads-highways", "/es-es/sector/sustainability", "/es-es/sector/telecom", "/es-es/sector/textiles-apparel", "/es-es/sector/textiles-apparel/handlooms-handicrafts", "/es-es/sector/textiles-apparel/man-made-fibres", "/es-es/sector/thermal-power", "/es-es/sector/tourism-hospitality", "/es-es/states", "/es-es/state/andaman-and-nicobar-islands", "/es-es/state/andhra-pradesh", "/es-es/state/arunachal-pradesh", "/es-es/state/assam", "/es-es/state/bihar", "/es-es/state/chandigarh", "/es-es/state/chhattisgarh", "/es-es/state/dadra-and-nagar-haveli-and-daman-and-diu", "/es-es/state/delhi", "/es-es/state/goa", "/es-es/state/gujarat", "/es-es/state/haryana", "/es-es/state/himachal-pradesh", "/es-es/state/jammu-and-kashmir", "/es-es/state/jharkhand", "/es-es/state/karnataka", "/es-es/state/kerala", "/es-es/state/ladakh", "/es-es/state/lakshadweep-islands", "/es-es/state/madhya-pradesh", "/es-es/state/maharashtra", "/es-es/state/manipur", "/es-es/state/meghalaya", "/es-es/state/mizoram", "/es-es/state/nagaland", "/es-es/state/odisha", "/es-es/state/puducherry", "/es-es/state/punjab", "/es-es/state/rajasthan", "/es-es/state/sikkim", "/es-es/state/tamil-nadu", "/es-es/state/telangana", "/es-es/state/tripura", "/es-es/state/uttar-pradesh", "/es-es/state/uttarakhand", "/es-es/state/west-bengal", "/es-esjavascript:void(0)", "/es-es/country/australia", "/es-es/country/canada", "/es-es/country/china", "/es-es/country/france", "/es-es/country/germany", "/es-es/country/israel", "/es-es/country/italy", "/es-es/country/japan-plus", "/es-es/country/korea-plus", "/es-es/country/russia-plus", "/es-es/country/saudi-arabia", "/es-es/country/sweden", "/es-es/country/taiwan-plus", "/es-es/country/united-arab-emirates", "/es-es/country/united-kingdom", "/es-es/country/united-states", "/es-esjavascript:void(0)", "/es-esjavascript:void(0)", "/es-esjavascript:void(0)", "/es-es/atmanirbhar-bharat-abhiyaan", "/es-es/key-policies-and-schemes", "/es-es/loan-guarantee-scheme-covid-affected-sectors", "/es-es/production-linked-incentives-schemes-india", "/es-es/schemes-msmes-india", "/es-es/technology-development-fund", "/es-es/magazine", "https://g20.investindia.gov.in", "https://www.investindia.gov.in/union-budget-2022-23", "/es-esjavascript:void(0)", "/es-esjavascript:void(0)", "/es-es/setting-up-business-in-india", "/es-es/exim", "/es-es/faqs/sectoral", "/es-es/foreign-direct-investment", "/es-es/great-places-for-manufacturing-in-india", "/es-es/taxation", "/es-es/visa", "/es-es/why-india", "/es-esjavascript:void(0)", "/es-es/team-india-blogs", "/es-es/policies-research-reports", "/es-es/contact-us?", null, "/es-es/sector/pharmaceuticals", "/fr-fr/sector/pharmaceuticals", "/de-de/sector/pharmaceuticals", "/ja-jp/sector/pharmaceuticals", "/ko-kr/sector/pharmaceuticals", "/zh-cn/sector/pharmaceuticals", "/zh-tw/sector/pharmaceuticals", "/pt-br/sector/pharmaceuticals", "/ru-ru/sector/pharmaceuticals", "/es-es/sector/pharmaceuticals", "#lang-popup", "/contact-us?", null, "/contact-us?", "/es-es", "/es-es/sectors", null, null, null, null, null, null, null, null, null, null, null, "https://www.investindia.gov.in/foreign-direct-investment", "https://iis.ncog.gov.in/login1", "https://pib.gov.in/PressReleasePage.aspx?PRID=1956909", "https://pib.gov.in/PressReleasePage.aspx?PRID=1949414", "https://pib.gov.in/PressReleasePage.aspx?PRID=1945155", "https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/corning-sgd-pharma-to-set-up-glass-tubing-vials-unit-in-telangana/articleshow/100858271.cms", "https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/laurus-labs-invests-rs-80-crore-in-cell-gene-therapy-firm-immunoact/articleshow/100655546.cms", "/team-india-news", "JavaScript:Void(0);", "https://static.investindia.gov.in/s3fs-public/2020-10/FDI-PolicyCircular-2020.pdf", "https://iis.ncog.gov.in/parks/login1", "https://ncog.gov.in/IIS/login1", "https://static.investindia.gov.in/s3fs-public/2020-07/Skill%20Index_0.pdf", "https://static.investindia.gov.in/s3fs-public/2020-07/Skill%20Index_0.pdf", "https://static.investindia.gov.in/s3fs-public/2020-07/doing-business-in-india-2020_0.pdf", "https://static.investindia.gov.in/s3fs-public/2020-07/doing-business-in-india-2020_0.pdf", "https://www.investindia.gov.in/siru/helping-india-breatheventilator-manufacturing-during-covid-19", "https://www.investindia.gov.in/siru/helping-india-breathe-ventilator-manufacturing-during-covid-19", "https://static.investindia.gov.in/s3fs-public/2019-06/PharmaBrochure_v2%20%281%29_0.pdf", "https://static.investindia.gov.in/s3fs-public/2019-06/PharmaBrochure_v2%20%281%29_0.pdf", "http://niper.gov.in/about.htm", "https://pharmaceuticals.gov.in/sites/default/files/National%20Pharmaceutical%20Pricing%20Policy%202012_1.pdf", "https://www.nhp.gov.in/drugs-and-pharmaceuticals_pg", "http://pharmaceuticals.gov.in/sites/default/files/CDP-PS_0.pdf", "https://www.ibef.org/industry/pharmaceutical-india.aspx", "/frequently-asked-questions?category=7#tabs-82", "https://static.investindia.gov.in/s3fs-public/2020-08/Economy%20Watch%20August%202020.pdf", "https://static.investindia.gov.in/s3fs-public/2020-08/COVID-19%20Infection%20Prevention%20and%20Control%20-%20Communication%20Toolkit%20for%20Long-Term%20Care%20Facilities.pdf", "https://static.investindia.gov.in/s3fs-public/2020-08/Digital_ExportPreparednessIndex2020_0.pdf", "https://static.investindia.gov.in/s3fs-public/2020-08/Unlocking-Value-from-Data-and-AI%5D.pdf", "/market-research?field_sector_target_id=82", "http://pharmaceuticals.gov.in", "http://www.nppaindia.nic.in/", "http://www.nppaindia.nic.in/", "http://bdmai.org", "http://www.fopeindia.in/", "https://www.idma-assn.org", "http://www.ipa-india.org/", "https://www.indiaoppi.com", "http://pharmexcil.org/", "https://www.investindia.gov.in/setting-up-business-in-india", "https://www.investindia.gov.in/foreign-direct-investment", "https://www.investindia.gov.in/team-india-news", "https://www.investindia.gov.in/team-india-blogs", "/media-page", "#", "#", "/team-india-news", "/team-india-news/cabinet-approves-signing-mou-between-india-and-suriname-field-regulation-medicines", "/team-india-news/cabinet-approves-signing-mou-between-india-and-suriname-field-regulation-medicines", "/team-india-news/cabinet-approves-signing-mou-between-india-and-suriname-field-regulation-medicines", "#", "#", "https://www.investindia.gov.in/sector/pharmaceuticals", null, null, "#", "#", "/team-india-news", "/team-india-news/laurus-labs-invests-inr-80-cr-cell-gene-therapy-firm-immunoact", "/team-india-news/laurus-labs-invests-inr-80-cr-cell-gene-therapy-firm-immunoact", "/team-india-news/laurus-labs-invests-inr-80-cr-cell-gene-therapy-firm-immunoact", "#", "#", "/market-research", "https://static.investindia.gov.in/s3fs-public/2023-05/DPIIT_AnnualReportE_03March2023%20%281%29.pdf", "https://static.investindia.gov.in/s3fs-public/2023-05/DPIIT_AnnualReportE_03March2023%20%281%29.pdf", "#", "#", "/team-india-news", "/team-india-news/serum-institute-double-investment-biocons-unit-300-million", "/team-india-news/serum-institute-double-investment-biocons-unit-300-million", "/team-india-news/serum-institute-double-investment-biocons-unit-300-million", "#", "#", "/market-research", "https://static.investindia.gov.in/s3fs-public/2023-04/Economic%20Survey%20Complete%20PDF%202022-23.pdf", "https://static.investindia.gov.in/s3fs-public/2023-04/Economic%20Survey%20Complete%20PDF%202022-23.pdf", "#", "#", "/market-research", "https://static.investindia.gov.in/s3fs-public/2023-04/Annual%20Report%202022-23%20Final-3_0.pdf", "https://static.investindia.gov.in/s3fs-public/2023-04/Annual%20Report%202022-23%20Final-3_0.pdf", "#", "#", "/team-india-news", "/team-india-news/mankind-pharma-setting-inr-300-cr-fertility-hormone-manufacturing-unit-udaipur", "/team-india-news/mankind-pharma-setting-inr-300-cr-fertility-hormone-manufacturing-unit-udaipur", "/team-india-news/mankind-pharma-setting-inr-300-cr-fertility-hormone-manufacturing-unit-udaipur", "#", "#", "/market-research", "https://static.investindia.gov.in/s3fs-public/2023-04/Private%20Sector%20Engagement%20for%20Tuberculosis%20Elimination%20India%E2%80%99s%20Journey%20from%20Pilots%20to%20National%20Scale-Up%20%282012%E2%80%932021%29.pdf", "https://static.investindia.gov.in/s3fs-public/2023-04/Private%20Sector%20Engagement%20for%20Tuberculosis%20Elimination%20India%E2%80%99s%20Journey%20from%20Pilots%20to%20National%20Scale-Up%20%282012%E2%80%932021%29.pdf", "#", "#", "/market-research", "https://static.investindia.gov.in/s3fs-public/2023-03/Annual%20Report%202022-23_Department%20of%20Pharmaceuticals.pdf", "https://static.investindia.gov.in/s3fs-public/2023-03/Annual%20Report%202022-23_Department%20of%20Pharmaceuticals.pdf", "#", "#", "/team-india-news", "/team-india-news/sanofi-launches-new-long-acting-insulin-drug-india", "/team-india-news/sanofi-launches-new-long-acting-insulin-drug-india", "/team-india-news/sanofi-launches-new-long-acting-insulin-drug-india", "#", "#", "/team-india-news", "/team-india-news/domestic-pharma-industry-revenues-expected-grow-6-8-pc-next-fiscal", "/team-india-news/domestic-pharma-industry-revenues-expected-grow-6-8-pc-next-fiscal", "/team-india-news/domestic-pharma-industry-revenues-expected-grow-6-8-pc-next-fiscal", "#", "#", "/team-india-news", "/team-india-news/bristol-myers-set-drug-development-centre-hyderabad", "/team-india-news/bristol-myers-set-drug-development-centre-hyderabad", "/team-india-news/bristol-myers-set-drug-development-centre-hyderabad", "#", "#", "/team-india-news", "/team-india-news/aurobindo-pharmas-three-units-telangana-gets-vai-classification-usfda-shares-gain", "/team-india-news/aurobindo-pharmas-three-units-telangana-gets-vai-classification-usfda-shares-gain", "/team-india-news/aurobindo-pharmas-three-units-telangana-gets-vai-classification-usfda-shares-gain", "#", "#", "/market-research", "https://static.investindia.gov.in/s3fs-public/2023-02/PP.pdf", "https://static.investindia.gov.in/s3fs-public/2023-02/PP.pdf", "/media-page", "/media-page", "mailto:contact@investindia.org.in", "tel:+91-11-23048155", "https://twitter.com/investindia", "https://www.linkedin.com/company/invest-india/", "https://www.youtube.com/channel/UCcw6X2Vh07Dr_2iU2uCKORQ", "https://www.instagram.com/investindiaofficial/", "/es-es/about-us", "/es-es/contact-us?", "/es-es/careers", "/es-es/success-stories", "/es-es/invest-india-partners", "/es-es/policies-research-reports", "/es-es/invest-india-team", "/es-es/agnii", "/es-es/bonded-manufacturing", "/es-es/financial-investors-initiative", "/es-es/invest-india-grid", "https://www.nsws.gov.in/", "/es-es/one-district-one-product", "https://pmg.dpiit.gov.in/", "/es-es/pio-investor-helpdesk", "/es-es/corporate-social-responsibility", "/es-es/startup-india-hub", "/es-es/indian-unicorn-landscape", "/es-es/waste-to-wealth", "/es-es/states", "/es-es/sectors", "/es-es/country/australia", "/es-es/country/canada", "/es-es/country/china", "/es-es/country/france", "/es-es/country/germany", "/es-es/country/israel", "/es-es/country/italy", "/es-es/country/japan-plus", "/es-es/country/korea-plus", "/es-es/country/russia-plus", "/es-es/country/saudi-arabia", "/es-es/country/taiwan-plus", "/es-es/country/united-arab-emirates", "/es-es/country/united-kingdom", "/es-es/country/united-states", "/es-es/atmanirbhar-bharat-abhiyaan", "/es-es/key-policies-and-schemes", "/es-es/central-services-window", "https://iis.ncog.gov.in/parks/login1", "/es-es/loan-guarantee-scheme-covid-affected-sectors", "/es-es/production-linked-incentives-schemes-india", "/es-es/schemes-msmes-india", "/es-es/technology-development-fund", "/es-es/team-india-blogs", "/es-es/pm-stiac", "/es-es/magazine", "/es-es/policies-research-reports", "/es-es/setting-up-business-in-india", "/es-es/exim", "/es-es/faqs/sectoral", "/es-es/foreign-direct-investment", "/es-es/great-places-for-manufacturing-in-india", "/es-es/taxation", "/es-es/visa", "/es-es/why-india", "/es-es/schemes-for-electronics-manufacturing", "/es-es/schemes-for-medical-devices-manufacturing", "https://static.investindia.gov.in/s3fs-public/inline-files/Suggestive%20Detail%20Project%20Report%28DPR%29%20format.pdf", "/es-es/invest-india-sustainability-framework", "/es-es/request-for-proposal", "/es-es/events", "https://www.nic.in/", "http://www.mea.gov.in/", "https://rtionline.gov.in/", "/privacy-policy", "/terms-of-use-and-disclaimer", "/contact-us"]}